COG vs. FDBK, INHC, RENX, VRCI, SBTX, SAR, OBD, ONC, DEST, and OPTI
Should you be buying Cambridge Cognition stock or one of its competitors? The main competitors of Cambridge Cognition include Feedback (FDBK), Induction Healthcare Group (INHC), Renalytix (RENX), Verici Dx (VRCI), SkinBioTherapeutics (SBTX), Sareum (SAR), Oxford BioDynamics (OBD), Oncimmune (ONC), Destiny Pharma (DEST), and OptiBiotix Health (OPTI). These companies are all part of the "medical" sector.
Cambridge Cognition (LON:COG) and Feedback (LON:FDBK) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, analyst recommendations, dividends, community ranking, valuation, risk, institutional ownership and earnings.
36.4% of Cambridge Cognition shares are held by institutional investors. Comparatively, 52.8% of Feedback shares are held by institutional investors. 28.2% of Cambridge Cognition shares are held by insiders. Comparatively, 11.0% of Feedback shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Cambridge Cognition had 9 more articles in the media than Feedback. MarketBeat recorded 9 mentions for Cambridge Cognition and 0 mentions for Feedback. Cambridge Cognition's average media sentiment score of 0.03 beat Feedback's score of 0.00 indicating that Cambridge Cognition is being referred to more favorably in the media.
Feedback received 60 more outperform votes than Cambridge Cognition when rated by MarketBeat users. Likewise, 67.07% of users gave Feedback an outperform vote while only 44.30% of users gave Cambridge Cognition an outperform vote.
Feedback has a net margin of 0.00% compared to Cambridge Cognition's net margin of -29.25%. Feedback's return on equity of -32.67% beat Cambridge Cognition's return on equity.
Feedback has lower revenue, but higher earnings than Cambridge Cognition. Cambridge Cognition is trading at a lower price-to-earnings ratio than Feedback, indicating that it is currently the more affordable of the two stocks.
Cambridge Cognition has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500. Comparatively, Feedback has a beta of 0.89, meaning that its stock price is 11% less volatile than the S&P 500.
Summary
Feedback beats Cambridge Cognition on 9 of the 15 factors compared between the two stocks.
Get Cambridge Cognition News Delivered to You Automatically
Sign up to receive the latest news and ratings for COG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding COG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cambridge Cognition Competitors List
Related Companies and Tools
